Primary Site >> Stomach Cancer
Gene >> MECP2
| 1. | |||||||||||
| Journal: | World J Gastroenterol. 2004 Dec 1;10(23):3394-8. | ||||||||||
| Title: | Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. | ||||||||||
| Author: | Fang, Jing-Yuan|Cheng, Zhong-Hua|Chen, Ying-Xuan|Lu, Rong|Yang, Li|Zhu, Hong-Yin|Lu, Lun-Gen | ||||||||||
| PMID: | 15526354 | ||||||||||
| 2. | |||||||||||
| Journal: | Am J Physiol Cell Physiol. 2007 Feb;292(2):C857-66. Epub 2006 Sep 20. | ||||||||||
| Title: | Epigenetic regulation of integrin-linked kinase expression depending on adhesion of gastric carcinoma cells. | ||||||||||
| Author: | Kim, Yong-Bae|Lee, Sung-Yul|Ye, Sang-Kyu|Lee, Jung Weon | ||||||||||
| PMID: | 16987993 | ||||||||||
| 3. | |||||||||||
| Journal: | Int J Cancer. 2010 Sep 1;127(5):1106-14. | ||||||||||
| Title: | miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. | ||||||||||
| Author: | Wada, Rie|Akiyama, Yoshimitsu|Hashimoto, Yutaka|Fukamachi, Hiroshi|Yuasa, Yasuhito | ||||||||||
| PMID: | 20020497 | ||||||||||
| 4. | |||||||||||
| Journal: | PLoS One. 2013 May 8;8(5):e62589. | ||||||||||
| Title: | Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. | ||||||||||
| Author: | Hashimoto, Yutaka|Akiyama, Yoshimitsu|Yuasa, Yasuhito | ||||||||||
| PMID: | 23667495 | ||||||||||
| 5. | |||||||||||
| Journal: | Acta Histochem Cytochem. 2015 Aug 27;48(4):115-24. | ||||||||||
| Title: | Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory. | ||||||||||
| Author: | Kameoka, Yuri|Kitazawa, Riko|Ariasu, Kanazu|Tachibana, Ryosuke|Mizuno, Yosuke|Haraguchi, Ryuma|Kitazawa, Sohei | ||||||||||
| PMID: | 26379313 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncotarget. 2016 Jan 26;7(4):4195-209. | ||||||||||
| Title: | Epigenetic modification of TLR4 promotes activation of NF-kappaB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. | ||||||||||
| Author: | Kim, Tae Woo|Lee, Seon-Jin|Oh, Byung Moo|Lee, Heesoo|Uhm, Tae Gi|Min, Jeong-Ki|Park, Young-Jun|Yoon, Suk Ran|Kim, Bo-Yeon|Kim, Jong Wan|Choe, Yong-Kyung|Lee, Hee Gu | ||||||||||
| PMID: | 26675260 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncotarget. 2016 Jun 7;7(23):34845-59. | ||||||||||
| Title: | MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect. | ||||||||||
| Author: | Tong, Dongdong|Zhao, Lingyu|He, Kang|Sun, Hongfei|Cai, Donghui|Ni, Lei|Sun, Ruifang|Chang, Su'e|Song, Tusheng|Huang, Chen | ||||||||||
| PMID: | 27166996 | ||||||||||
| 8. | |||||||||||
| Journal: | Glycobiology. 2017 Apr 1;27(4):306-317. | ||||||||||
| Title: | MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells. | ||||||||||
| Author: | Qin, Yannan|Zhao, Lingyu|Wang, Xiaofei|Tong, Dongdong|Hoover, Christopher|Wu, Fei|Liu, Yingxun|Wang, Lumin|Liu, Liying|Ni, Lei|Song, Tusheng|Huang, Chen | ||||||||||
| PMID: | 28100567 | ||||||||||
| 9. | |||||||||||
| Journal: | EBioMedicine. 2017 Feb;16:87-100. | ||||||||||
| Title: | MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/beta-Catenin and MYOD1/Caspase-3 Signaling Pathways. | ||||||||||
| Author: | Zhao, Lingyu|Liu, Yingxun|Tong, Dongdong|Qin, Yannan|Yang, Juan|Xue, Meng|Du, Ning|Liu, Liying|Guo, Bo|Hou, Ni|Han, Jia|Liu, Siyuan|Liu, Na|Zhao, Xiaoge|Wang, Lumin|Chen, Yanke|Huang, Chen | ||||||||||
| PMID: | 28131747 | ||||||||||
| 10. | |||||||||||
| Journal: | Oncogenesis. 2017 Jul 31;6(7):e368. | ||||||||||
| Title: | MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2-ERK1/2 signaling pathway by upregulating GIT1. | ||||||||||
| Author: | Zhao, L Y|Tong, D D|Xue, M|Ma, H L|Liu, S Y|Yang, J|Liu, Y X|Guo, B|Ni, L|Liu, L Y|Qin, Y N|Wang, L M|Zhao, X G|Huang, C | ||||||||||
| PMID: | 28759023 | ||||||||||
| 11. | |||||||||||
| Journal: | Medicine (Baltimore). 2017 Aug;96(31):e7691. | ||||||||||
| Title: | MECP2 expression in gastric cancer and its correlation with clinical pathological parameters. | ||||||||||
| Author: | Zhang, Jing|Zhao, Junmei|Gao, Ning|Wang, Yanfeng|Chen, Yani|Han, Jiming | ||||||||||
| PMID: | 28767600 | ||||||||||
| 12. | |||||||||||
| Journal: | Int J Mol Med. 2018 Jul;42(1):228-236. | ||||||||||
| Title: | miR-19a/b and MeCP2 repress reciprocally to regulate multidrug resistance in gastric cancer cells. | ||||||||||
| Author: | Zhu, Fei|Wu, Qiong|Ni, Zhen|Lei, Chao|Li, Ting|Shi, Yongquan | ||||||||||
| PMID: | 29568890 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncol Lett. 2018 Aug;16(2):1931-1936. | ||||||||||
| Title: | DNA methylation contributes to silencing the expression of linc00086 in gastric cancer. | ||||||||||
| Author: | Yang, Yang|Li, Yulong|Zhao, Zhenghao|Sun, Ruifang|Jiang, Qiuyu|Zhao, Lingyu|Wang, Lumin|Liu, Yingxun|Wu, Fei|Shi, Xingmin|Huang, Chen|Shao, Yuan | ||||||||||
| PMID: | 30008886 | ||||||||||